Latest News

We focus on local and international deals up to US$500 million in value across a wide range of sectors. Since the start of 2012 our partner firms have collectively completed over 230 deals, in 30 countries worldwide with an aggregate value of over US$17.5 billion.

Going Public Magazine interviews Stefan Constantin of C.H Reynolds on Biotech

10th May 2011

When thinking about M&A transactions in white biotechnology, there are some particularities that need to be observed as they don’t occur in other industries including red biotech.

GoingPublic magazine interview with Stefan Constantin, Partner, C H Reynolds Corporate Finance AG. Download the attached PDF at the bottom of page for the original article. When thinking about M&A transactions in white biotechnology, there are some particularities that need to be observed as they don’t occur in other industries including red biotech. M&A consultant Stefan Constantin from C.H Reynolds explains what matters when making deals in industrial biotechnology. GoingPublic: Mr Constantin, you executed several deals in the white biotechnology field. What are the particularities compared to other industries? Constantin: Generally, we are talking about technology transactions more than sales or profitability driven transactions. Often, the size of the target company is only a small fraction of the size of the buyer. The turn - over range of most targets lies between single-digit and double-digit millions, whereas buyers are often medium-sized or multi-billion companies. Another particularity is that the span of the potential buyers universe is much wider than in other industries. GoingPublic: Does this refer to industries as well as to company sizes? Constantin: Yes, but it also shows the different positions in the value chain. The range of interested companies varies from big chemical and pharmaceutical players producing patented consumer end products, generics, detergents, food supplements or scent and flavor substances to active ingredient (API-)manufacturers or medium-sized or big suppliers of inter mediates. Real Biotech-Competitors show interest in acquisitions as well although only few of them are financially strong enough to acquire. Depending on the development stage of the target company, corporate VCs are amongst the interested parties, too. GoingPublic: Is the acquisition of technology the main driver, or do competitive aspects also play a role? Constantin: As part of the sales process you have to bear in mind different aims for each interested group. Companies like Pfizer, Boehringer or Henkel as well as big suppliers are interested in the savings within their own production process, e.g. replacing three chemical steps by one organic step. Competitors are more interested in complementarity or in different technologies. GoingPublic: What exactly are the differences between the red and white biotechnology in terms of trans actions? Constantin: There are huge differences in relation to the structures of transactions: The white biotech business model is often wider in potential applications and contains out-licensing and co-operations with big companies already. The business models in the red biotech area are more focused with every clinical phase, leaving diagnostics and other red biotechs aside. As a consequence, the range of potential exit buyers rather gets smaller than bigger as the company progresses. Additionally, red biotech companies are ultimately bought when their development phase is coming to an end. In the area of oncology for example, there are in certain situations only five or six global players that can be considered as potential buyers. GoingPublic: Do white biotech companies have to reach a certain stage of development in order to raise interest, or is technology itself the main driver? Constantin: In contrast to the red biotech industry where each clinical phase reached limits products, and helps for the next financing round, even young white biotech companies can raise an enormous amount of interest. What matters is whether they are able to prove the functionality of their products in large scale areas. We think that at least two or three anchor projects in the context of co-operations or out-licensing with industrial partners are necessary to get the sales process going. GoingPublic: Which role do VC and Private Equity play in the early stage of financing as well as on the vendor side? Constantin: VC investors play a dominant role in financing. At a certain time, they are looking for exit possibilities. They have to support the management in their clear strategy in order to gain sufficient return on investment. Therefore company structures with regard to IP and sales force have to be positioned in such a way that they can be introduced into the market. In other words: Organizational support and strategic investments are needed. VC alone cannot always deliver that. Due to the sizes of investments, Private Equity rather plays a supporting role as developments in white biotech are part of their equity stories for the bigger investments like Cognis, Evonik or Süd-Chemie, being hold or held by Permira, CVC or OEP. In white biotech, Private Equity is rarely seen as direct buyer. GoingPublic: Even though VC-financing plays a dominant role, isn’t there a need to catch up in comparison to the red biotechnology? Constantin: Yes, absolutely. Playing a dominant role in this case does not necessarily mean: on a high level. In Europe and the U.S., there is only a limited number of VC-financed white biotech companies. Their number is rising, also due to cost pressure within the pharma/ chemical industry and the suppliers. This is underpinned by the increase in co-operations. GoingPublic: In Germany, white biotech has not yet entered the stock exchange … Constantin:We think that there are four reasons for this: First, we are talking about extremely complex products or processes that can be introduced into several application areas. Furthermore, the business model requires technology to be up-scaled on an industrial level which needs further investment. Additionally, the question arises where the company will position itself in three or four years when it “should” also deal with sectors like the food industry. Can the company sufficiently grow without an exit to a strategic partner? Or will it be taken over and vanish from the stock markets? The equity story is important: Chances and risks are difficult to communicate to the market. GoingPublic: When listed on the stock market, the capital market could offer a reasonable financing alternative … Constantin: This is generally true, but to a certain extent, it depends on customers and products. B.R.A.I.N, an intelligently and broadly positioned company, is often considered as a stock market candidate. But sales teams for the different segments adhesives, pharmaceuticals etc. have to be financed – potentially also using Venture Capital. Again, the question arises: Where does the company want to stand in four years? A supplier for big players? There are other companies beyond the mark of EUR 300 million in sales able to either develop white biotech by themselves or to acquire it. GoingPublic: How important is the international aspect for transactions in white biotech? Constantin: An international capacity is crucial for selling white biotech companies. We felt that in all our processes. Some companies don’t pay attention to this size of potential targets, e.g. suppliers of the pharmaceutical industry with a turnover of 300 to 400 million Euros which themselves have been thinking about getting involved with biotechnology but didn’t make it. Addressing international companies on a strategic level is essential for success. GoingPublic: Not only across the borders, but also across continents? Constantin: Absolutely. Just look at Indian generics producers: They are observing the German market very carefully. GoingPublic: Mr Constantin, thank you very much for this informative interview. 109-67a80a2de604bc6e39d314af987088dd.pdf
Adobe Acrobat file - 0.4 mb

< Back

latest opinion

America First In The Trump Raj

US President Donald Trump has proposed a massive reduction in corporate tax rate to 15 per cent. The move, if passes muster, could be good for Indian companies but bad for the country.…

INDIAN ELECTIONS – IN THE PRICE

Indian state elections were announced over the weekend and the ruling party led by Prime Minister Modi- Bhartiya Janta Party (BJP) were the clear winners with a sweep in the key state Uttar Pradesh (UP)…

Strong M&A outlook for mid-market pharma

The dynamics highlighted by this year’s Catalyst Pharma Fast 50 show that the sector is prime for further acquisitions and private equity investment.…

Mega Indian Telco Merger: Better late than never

Two out of India's Top 3 telco operators, Vodafone (No 2) and Idea Cellular (No 3) confirmed their merger plan earlier this month.…

Industrial Distributor Sector Overview

The latest issue of our Industrial Technology Value-Added Distributors Sector Overview, highlighting trends in M&A, financing, IPOs and capital markets for private and public companies in Industrial Technology sector, is now available.…

Trump victory & scrapping of Notes. Near term jitters provide opportunities

Two major events-one domestic and other global, have led to market jitters which in our view present an opportunity for value buying…

Agricultural Equipment and Fertilizer Update

Recent activity in the agriculture space has shown continued consolidation and financing needs. Please see our update published recently.…

So they made an offer, now what?

Financial and strategic buyers are making offers directly to business owners…

Strategic HR: building an organisation culture to balance risk and return

It’s official: we are in a low-growth world, with the latest data revealing a slowdown in the US, Europe and Japan, as well as numerous developing markets.…

India never so close to Goods & Services Tax !!

While India has been trying to implement the Goods and Service Tax (GST) for the past six years, the country has never been so close. The GST is facing its biggest hurdle in the Upper House where the passing will require a two-thirds majority and where the distribution of seats is not in favour of the ruling NDA government.…

View more >

latest deals

/var/www/mergers/website/views/scripts/deals/feed.php:10:
array (size=7)
  'id' => int 976
  'completion_date' => string '2017-05-29T00:00:00+0000' (length=24)
  'publicised_transaction' => boolean false
  'hide_on_website' => boolean false
  'involved_users' => 
    array (size=3)
      0 => 
        array (size=2)
          'level' => int 0
          'user' => 
            array (size=1)
              ...
      1 => 
        array (size=2)
          'level' => int 1
          'user' => 
            array (size=1)
              ...
      2 => 
        array (size=2)
          'level' => int 2
          'user' => 
            array (size=1)
              ...
  'intro' => string 'Odin Financial Advisors advised iyzico in its Series C fundraising round, led by Vostok Emerging Finance, in order to boost expansion in Europe and Middle&hellip;' (length=162)
  'display_name' => string 'iyzico' (length=6)
iyzico

Odin Financial Advisors advised iyzico in its Series C fundraising round, led by Vostok Emerging Finance, in order to boost expansion in Europe and Middle…

/var/www/mergers/website/views/scripts/deals/feed.php:10:
array (size=7)
  'id' => int 977
  'completion_date' => string '2017-05-17T00:00:00+0000' (length=24)
  'publicised_transaction' => boolean false
  'hide_on_website' => boolean false
  'involved_users' => 
    array (size=4)
      0 => 
        array (size=2)
          'level' => int 0
          'user' => 
            array (size=1)
              ...
      1 => 
        array (size=2)
          'level' => int 1
          'user' => 
            array (size=1)
              ...
      2 => 
        array (size=2)
          'level' => int 2
          'user' => 
            array (size=1)
              ...
      3 => 
        array (size=2)
          'level' => int 2
          'user' => 
            array (size=1)
              ...
  'intro' => string 'Capitalmind advised SYLPA Group on its acquisition ENTRA Group in a competitive process. Following its third MBO backed by EPF Partners (PE fund) in July&hellip;' (length=161)
  'display_name' => string 'ENTRA' (length=5)
ENTRA

Capitalmind advised SYLPA Group on its acquisition ENTRA Group in a competitive process. Following its third MBO backed by EPF Partners (PE fund) in July…

/var/www/mergers/website/views/scripts/deals/feed.php:10:
array (size=7)
  'id' => int 972
  'completion_date' => string '2017-05-09T00:00:00+0000' (length=24)
  'publicised_transaction' => boolean false
  'hide_on_website' => boolean false
  'involved_users' => 
    array (size=3)
      0 => 
        array (size=2)
          'level' => int 0
          'user' => 
            array (size=1)
              ...
      1 => 
        array (size=2)
          'level' => int 1
          'user' => 
            array (size=1)
              ...
      2 => 
        array (size=2)
          'level' => int 2
          'user' => 
            array (size=1)
              ...
  'intro' => string 'The initiator, Dr. Dietrich Schrapper, a long term Capitalmind client, together with Ufenau has completed the first part of this transaction by acquiring the nucleus&hellip;' (length=173)
  'display_name' => string 'DermaClin Deutschland GmbH - Project Wilhelm' (length=44)
DermaClin Deutschland GmbH - Project Wilhelm

The initiator, Dr. Dietrich Schrapper, a long term Capitalmind client, together with Ufenau has completed the first part of this transaction by acquiring the nucleus…

/var/www/mergers/website/views/scripts/deals/feed.php:10:
array (size=7)
  'id' => int 971
  'completion_date' => string '2017-05-05T00:00:00+0000' (length=24)
  'publicised_transaction' => boolean false
  'hide_on_website' => boolean false
  'involved_users' => 
    array (size=4)
      0 => 
        array (size=2)
          'level' => int 0
          'user' => 
            array (size=1)
              ...
      1 => 
        array (size=2)
          'level' => int 1
          'user' => 
            array (size=1)
              ...
      2 => 
        array (size=2)
          'level' => int 2
          'user' => 
            array (size=1)
              ...
      3 => 
        array (size=2)
          'level' => int 2
          'user' => 
            array (size=1)
              ...
  'intro' => string 'i-SOLUTIONS Health is a provider of hospital / laboratory / radiology information systems. The company is an established brand on the German healthcare IT market&hellip;' (length=169)
  'display_name' => string 'i-SOLUTIONS HEALTH GmbH' (length=23)
i-SOLUTIONS HEALTH GmbH

i-SOLUTIONS Health is a provider of hospital / laboratory / radiology information systems. The company is an established brand on the German healthcare IT market…

/var/www/mergers/website/views/scripts/deals/feed.php:10:
array (size=7)
  'id' => int 970
  'completion_date' => string '2017-04-28T00:00:00+0000' (length=24)
  'publicised_transaction' => boolean false
  'hide_on_website' => boolean false
  'involved_users' => 
    array (size=2)
      0 => 
        array (size=2)
          'level' => int 0
          'user' => 
            array (size=1)
              ...
      1 => 
        array (size=2)
          'level' => int 1
          'user' => 
            array (size=1)
              ...
  'intro' => string 'Headwaters MB advised Neya Systems LLC, a leading developer of unmanned systems for defense, homeland security, and commercial users, on its sale to Applied Research&hellip;' (length=173)
  'display_name' => string 'Neya Systems' (length=12)
Neya Systems

Headwaters MB advised Neya Systems LLC, a leading developer of unmanned systems for defense, homeland security, and commercial users, on its sale to Applied Research…

/var/www/mergers/website/views/scripts/deals/feed.php:10:
array (size=7)
  'id' => int 974
  'completion_date' => string '2017-04-20T00:00:00+0000' (length=24)
  'publicised_transaction' => boolean false
  'hide_on_website' => boolean false
  'involved_users' => 
    array (size=6)
      0 => 
        array (size=2)
          'level' => int 0
          'user' => 
            array (size=1)
              ...
      1 => 
        array (size=2)
          'level' => int 1
          'user' => 
            array (size=1)
              ...
      2 => 
        array (size=2)
          'level' => int 2
          'user' => 
            array (size=1)
              ...
      3 => 
        array (size=2)
          'level' => int 2
          'user' => 
            array (size=1)
              ...
      4 => 
        array (size=2)
          'level' => int 2
          'user' => 
            array (size=1)
              ...
      5 => 
        array (size=2)
          'level' => int 2
          'user' => 
            array (size=1)
              ...
  'intro' => string 'Catalyst advised LDC on the secondary management buy-out of Addo Food Group.' (length=76)
  'display_name' => string 'Addo Food Group' (length=15)
Addo Food Group

Catalyst advised LDC on the secondary management buy-out of Addo Food Group.

/var/www/mergers/website/views/scripts/deals/feed.php:10:
array (size=7)
  'id' => int 986
  'completion_date' => string '2017-04-13T00:00:00+0000' (length=24)
  'publicised_transaction' => boolean false
  'hide_on_website' => boolean false
  'involved_users' => 
    array (size=5)
      0 => 
        array (size=2)
          'level' => int 0
          'user' => 
            array (size=1)
              ...
      1 => 
        array (size=2)
          'level' => int 1
          'user' => 
            array (size=1)
              ...
      2 => 
        array (size=2)
          'level' => int 2
          'user' => 
            array (size=1)
              ...
      3 => 
        array (size=2)
          'level' => int 2
          'user' => 
            array (size=1)
              ...
      4 => 
        array (size=2)
          'level' => int 2
          'user' => 
            array (size=1)
              ...
  'intro' => string 'Headwaters MB advised RAGE Frameworks, a leader in knowledge-based automation technology and services providing Artificial Intelligence (AI) for the Enterprise, on its sale to Genpact&hellip;' (length=191)
  'display_name' => string 'Rage Frameworks, Inc.' (length=21)
Rage Frameworks, Inc.

Headwaters MB advised RAGE Frameworks, a leader in knowledge-based automation technology and services providing Artificial Intelligence (AI) for the Enterprise, on its sale to Genpact…

/var/www/mergers/website/views/scripts/deals/feed.php:10:
array (size=7)
  'id' => int 957
  'completion_date' => string '2017-04-04T00:00:00+0000' (length=24)
  'publicised_transaction' => boolean false
  'hide_on_website' => boolean false
  'involved_users' => 
    array (size=3)
      0 => 
        array (size=2)
          'level' => int 0
          'user' => 
            array (size=1)
              ...
      1 => 
        array (size=2)
          'level' => int 1
          'user' => 
            array (size=1)
              ...
      2 => 
        array (size=2)
          'level' => int 2
          'user' => 
            array (size=1)
              ...
  'intro' => string 'Capitalmind advised, Normec, a Dutch group of TIC companies with an active Buy&Build strategy, on the acquisition of BVI' (length=120)
  'display_name' => string 'BVI' (length=3)
BVI

Capitalmind advised, Normec, a Dutch group of TIC companies with an active Buy&Build strategy, on the acquisition of BVI

/var/www/mergers/website/views/scripts/deals/feed.php:10:
array (size=7)
  'id' => int 953
  'completion_date' => string '2017-03-29T00:00:00+0000' (length=24)
  'publicised_transaction' => boolean false
  'hide_on_website' => boolean false
  'involved_users' => 
    array (size=4)
      0 => 
        array (size=2)
          'level' => int 0
          'user' => 
            array (size=1)
              ...
      1 => 
        array (size=2)
          'level' => int 1
          'user' => 
            array (size=1)
              ...
      2 => 
        array (size=2)
          'level' => int 2
          'user' => 
            array (size=1)
              ...
      3 => 
        array (size=2)
          'level' => int 3
          'user' => 
            array (size=1)
              ...
  'intro' => string 'Experia corporate finance advisors advised the owners of Nordentic, Dentacon, on the sale of the company to Adelis Equity partners.' (length=131)
  'display_name' => string 'Nordentic - Griffin' (length=19)
Nordentic - Griffin

Experia corporate finance advisors advised the owners of Nordentic, Dentacon, on the sale of the company to Adelis Equity partners.

/var/www/mergers/website/views/scripts/deals/feed.php:10:
array (size=7)
  'id' => int 978
  'completion_date' => string '2017-03-17T00:00:00+0000' (length=24)
  'publicised_transaction' => boolean false
  'hide_on_website' => boolean false
  'involved_users' => 
    array (size=3)
      0 => 
        array (size=2)
          'level' => int 0
          'user' => 
            array (size=1)
              ...
      1 => 
        array (size=2)
          'level' => int 1
          'user' => 
            array (size=1)
              ...
      2 => 
        array (size=2)
          'level' => int 2
          'user' => 
            array (size=1)
              ...
  'intro' => string 'Catalyst advised the shareholders of Thompson & Morgan Group Holdings, including Primary Capital, on the sale to BVG Group.

We were appointed to identify private equity&hellip;' (length=179)
  'display_name' => string 'Thomson & Morgan' (length=16)
Thomson & Morgan

Catalyst advised the shareholders of Thompson & Morgan Group Holdings, including Primary Capital, on the sale to BVG Group.

We were appointed to identify private equity…

/var/www/mergers/website/views/scripts/deals/feed.php:10:
array (size=7)
  'id' => int 963
  'completion_date' => string '2017-03-15T00:00:00+0000' (length=24)
  'publicised_transaction' => boolean false
  'hide_on_website' => boolean false
  'involved_users' => 
    array (size=4)
      0 => 
        array (size=2)
          'level' => int 0
          'user' => 
            array (size=1)
              ...
      1 => 
        array (size=2)
          'level' => int 1
          'user' => 
            array (size=1)
              ...
      2 => 
        array (size=2)
          'level' => int 2
          'user' => 
            array (size=1)
              ...
      3 => 
        array (size=2)
          'level' => int 2
          'user' => 
            array (size=1)
              ...
  'intro' => string 'Davilex was sold to Visma (Norway), a provider of business software, outsourcing services, commerce solutions, retail IT solutions, and IT related development and consultancy' (length=174)
  'display_name' => string 'Davilex' (length=7)
Davilex

Davilex was sold to Visma (Norway), a provider of business software, outsourcing services, commerce solutions, retail IT solutions, and IT related development and consultancy

/var/www/mergers/website/views/scripts/deals/feed.php:10:
array (size=7)
  'id' => int 960
  'completion_date' => string '2017-03-14T00:00:00+0000' (length=24)
  'publicised_transaction' => boolean false
  'hide_on_website' => boolean false
  'involved_users' => 
    array (size=5)
      0 => 
        array (size=2)
          'level' => int 0
          'user' => 
            array (size=1)
              ...
      1 => 
        array (size=2)
          'level' => int 1
          'user' => 
            array (size=1)
              ...
      2 => 
        array (size=2)
          'level' => int 2
          'user' => 
            array (size=1)
              ...
      3 => 
        array (size=2)
          'level' => int 2
          'user' => 
            array (size=1)
              ...
      4 => 
        array (size=2)
          'level' => int 2
          'user' => 
            array (size=1)
              ...
  'intro' => string 'Catalyst advised Phoenix Equity Partners on its investment in Global Freight Solutions (GFS) alongside the current management team, led by CEO Neil Cotty.

Phoenix will work&hellip;' (length=183)
  'display_name' => string 'Global Freight Solutions' (length=24)
Global Freight Solutions

Catalyst advised Phoenix Equity Partners on its investment in Global Freight Solutions (GFS) alongside the current management team, led by CEO Neil Cotty.

Phoenix will work…

/var/www/mergers/website/views/scripts/deals/feed.php:10:
array (size=7)
  'id' => int 961
  'completion_date' => string '2017-03-02T00:00:00+0000' (length=24)
  'publicised_transaction' => boolean false
  'hide_on_website' => boolean false
  'involved_users' => 
    array (size=5)
      0 => 
        array (size=2)
          'level' => int 0
          'user' => 
            array (size=1)
              ...
      1 => 
        array (size=2)
          'level' => int 1
          'user' => 
            array (size=1)
              ...
      2 => 
        array (size=2)
          'level' => int 2
          'user' => 
            array (size=1)
              ...
      3 => 
        array (size=2)
          'level' => int 2
          'user' => 
            array (size=1)
              ...
      4 => 
        array (size=2)
          'level' => int 2
          'user' => 
            array (size=1)
              ...
  'intro' => string 'Capitalmind Benelux advised Schutter on the sale to Bureau Veritas. This provides new capabilities and further expands Bureau Veritas’ footprint in agri-commodities in Europe, South&hellip;' (length=191)
  'display_name' => string 'Schutter Group B.V.' (length=19)
Schutter Group B.V.

Capitalmind Benelux advised Schutter on the sale to Bureau Veritas. This provides new capabilities and further expands Bureau Veritas’ footprint in agri-commodities in Europe, South…

/var/www/mergers/website/views/scripts/deals/feed.php:10:
array (size=7)
  'id' => int 962
  'completion_date' => string '2017-02-27T00:00:00+0000' (length=24)
  'publicised_transaction' => boolean false
  'hide_on_website' => boolean false
  'involved_users' => 
    array (size=3)
      0 => 
        array (size=2)
          'level' => int 0
          'user' => 
            array (size=1)
              ...
      1 => 
        array (size=2)
          'level' => int 1
          'user' => 
            array (size=1)
              ...
      2 => 
        array (size=2)
          'level' => int 2
          'user' => 
            array (size=1)
              ...
  'intro' => string 'Capitalmind advised the management of InterXion on the acquisition of the data center business from Vancis.' (length=107)
  'display_name' => string 'InterXion' (length=9)
InterXion

Capitalmind advised the management of InterXion on the acquisition of the data center business from Vancis.

/var/www/mergers/website/views/scripts/deals/feed.php:10:
array (size=7)
  'id' => int 954
  'completion_date' => string '2017-02-20T00:00:00+0000' (length=24)
  'publicised_transaction' => boolean false
  'hide_on_website' => boolean false
  'involved_users' => 
    array (size=3)
      0 => 
        array (size=2)
          'level' => int 0
          'user' => 
            array (size=1)
              ...
      1 => 
        array (size=2)
          'level' => int 1
          'user' => 
            array (size=1)
              ...
      2 => 
        array (size=2)
          'level' => int 3
          'user' => 
            array (size=1)
              ...
  'intro' => string 'The business, owned by three private individuals, had been through a successful refinancing in 2015 when a legacy private equity house fully exited the business.&hellip;' (length=169)
  'display_name' => string 'Raphael Healthcare' (length=18)
Raphael Healthcare

The business, owned by three private individuals, had been through a successful refinancing in 2015 when a legacy private equity house fully exited the business.…

View more >
'http://api.mergers-alliance.com/api/public'